Search for: "Sherry Knowles"
Results 1 - 20
of 53
Sorted by Relevance
|
Sort by Date
1 May 2014, 9:58 pm
Noonan -- Last week, Sherry Knowles, former chief patent counsel for GlaxoSmithKline and now principal at Knowles Intellectual Property Strategies, LLC submitted to Managing Intellectual Property magazine a detailed critique of the U.S. [read post]
15 Oct 2014, 9:34 pm
By Donald Zuhn -- Last month, at the Biotechnology Industry Organization (BIO) IP & Diagnostics Symposium in Alexandria, VA, Sherry Knowles of Knowles IP Strategies addressed the impact of the U.S. [read post]
22 May 2009, 6:58 pm
At that session, a panel consisting of Sherry Knowles (at right), Vice President of Corporate Intellectual Property at GlaxoSmithKline Biopharmaceuticals, Inc.; Q. [read post]
16 Jan 2019, 10:33 am
The post Sherry Knowles Scrutinizes an Activist Supreme Court and its Unconstitutional Approach to Patent Eligibility appeared first on IPWatchdog.com | Patents & Patent Law. [read post]
8 Dec 2014, 9:50 am
I recently had an opportunity to speak with Sherry Knowles (pictured left) on the record. [read post]
3 Jun 2019, 9:37 am
Below, Sherry Knowles, former Senior Vice President and Chief Patent Counsel at GlaxoSmithKline, rebuts the arguments made in both the ACLU’s briefing announcement and associated letter to Congress on this topic. [read post]
5 Dec 2014, 6:30 am
KNOWLES: "We are seeing a strong anti-innovation sentiment in the U.S. not just on the issue of obviousness but also on patent eligibility. [read post]
16 Jan 2019, 10:33 am
The post Sherry Knowles Scrutinizes an Activist... [read post]
11 Apr 2019, 9:59 pm
Knowles IP Strategies LLC (Sherry M. [read post]
9 Mar 2010, 3:13 pm
Note the article in the 26 Feb 2010 issue of Science, Fixing the Legal Framework for Pharmaceutical Research, by Sherry M. [read post]
31 Mar 2010, 10:44 pm
Noonan -- In a recent article in the journal Science, Sherry Knowles, the Chief Patent Counsel at GlaxoSmithKline, raises several interesting questions regarding the concept of "takings" of property in the patent context. [read post]
15 Apr 2010, 9:50 pm
By Donald Zuhn -- Sherry Knowles, Senior Vice President, Global Patents for GlaxoSmithKline has announced that she will be leaving GSK in June to start a consulting firm that will focus on IP management, business development, and monetizing assets in the area of pharmaceuticals, biopharmaceuticals, and medical devices. [read post]
18 Jan 2008, 10:08 pm
Let us praise CEO Jean-Pierre Garnier and IP VP Sherry Knowles of GlaxoSmithKline for carrying the torch as they scorch Senate Judiciary Committee bigwigs who have flipped their wigs to sashay with a toupee because of what they forgot to say; to aver the stead of not giving the PTO its head in capricious rulemaking. [read post]
20 Feb 2019, 8:43 pm
Noonan -- Sherry Knowles, former chief patent counsel of GlaxoSmithKline, and Dr. [read post]
20 May 2009, 8:55 pm
By Donald Zuhn -- In a Wednesday Super Session entitled "A Model Patent Office for the Future -- Promoting and Protecting Investments in Innovation," a panel consisting of Sherry Knowles, Vice President of Corporate Intellectual Property at GlaxoSmithKline Biopharmaceuticals, Inc.; Q. [read post]
23 Jun 2010, 9:59 pm
These realities come to mind when reviewing a letter from two medical students in the journal Science in response to an article by Sherry Knowles regarding patent law and the pharmaceutical industry. [read post]
5 Dec 2014, 6:30 am
KNOWLES: "We are seeing a strong anti-innovation sentiment in the U.S. not just on the issue of obviousness but also on patent eligibility. [read post]
6 Jun 2019, 1:15 pm
., LLC has been addressed by Sherry Knowles and Meredith Addy and is supported by a number of amicus briefs. [read post]
3 Dec 2014, 3:00 am
Sherry Knowles: "If a company identifies a weak patent now, it might file an inter partes review or post grant review at the U.S. [read post]
3 Dec 2014, 3:00 am
Sherry Knowles: "If a company identifies a weak patent now, it might file an inter partes review or post grant review at the U.S. [read post]
